NCT Number: NCT02106949
Short Message System (SMS) Monitoring Intended for the Suicidal Patients
The study wants to prove that SMS monitoring reduced the number of suicide attempts in six months according to the beginning of its implementation in the group of the patients benefiting SMS compared with the group of patients benefiting from the usual care.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
CHU Angers, Angers, France
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Written informed consent
- Surviving a suicide attempt
- Leaving directly the emergency department or hospitalized less than 7 days
- Being able to be joined by telephone mobile
Exclusion criteria
- under guardianship
- Patient who are not able to provide a consent
Treatment and study plan
Primary outcomes
-
Number of suicide reattempts in every group
Time frame: 6 months
Secondary outcomes
-
Number of suicide reattempts in every group
Time frame: 13 months
-
Total number of suicidal second recurrences in every group
Time frame: 6 months
-
Total number of suicidal second recurrences in every group
Time frame: 13 months
-
Number of deaths by suicide
Time frame: 6 months and 13 months
-
Score in the scale C-SSRS
Time frame: inclusion, 6 months and 13 months
-
Presence of a disorder in the MINI: characterization of the comorbidity
Time frame: 6 months and 13 months
Sponsors and collaborators
Lead sponsor
University Hospital, Brest
Other
Collaborators
- Technopôle Brest-Iroise: LANESTEL SARL, 38 rue Jim Sevellec, 29200 Brest
Registry information
Official study title
Short Message System (SMS) Monitoring Intended for the Suicidal Patients: Study of Efficiency
Important dates
- Study start
- 2014
- Primary completion
- 2019
- Study completion
- 2019
- First posted
- Apr 8, 2014
- Registry last updated
- Jan 23, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The 10-years REPEATERS Cohort of French Adolescents
NCT02887170
Behavior, Behavioral Symptoms
Nancy, France
View Trial DetailsMAPS Group Therapy Model for Bipolar Disorder
NCT01152034
Behavior, Behavioral Symptoms
Taipei, Taiwan
View Trial DetailsCMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
NCT01134575
Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Houston, Texas, United States
View Trial DetailsSalvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study
NCT05927558
B-cell Non Hodgkin Lymphoma, Disease Attributes
Milan, Italy
View Trial Details